Cargando…
Beta-Lactam Plus Macrolide for Patients Hospitalized With Community-Acquired Pneumonia: Difference Between Autumn and Spring
BACKGROUND: The 2017 Korean guideline on community-acquired pneumonia (CAP) recommended beta-lactam plus macrolide combination therapy for patients hospitalized with severe pneumonia, and beta-lactam monotherapy for mild-to-moderate pneumonia. However, antibiotic treatment regimen for mild-to-modera...
Autores principales: | Kim, Yoonjung, Jeon, Yena, Kwon, Ki Tae, Bae, Sohyun, Hwang, Soyoon, Chang, Hyun-Ha, Kim, Shin-Woo, Lee, Won Kee, Yang, Ki-Hwa, Shin, Ji-Hyeon, Shim, Eun-Kyung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Academy of Medical Sciences
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9678659/ https://www.ncbi.nlm.nih.gov/pubmed/36413797 http://dx.doi.org/10.3346/jkms.2022.37.e324 |
Ejemplares similares
-
Is β-Lactam Plus Macrolide More Effective than β-Lactam Plus Fluoroquinolone among Patients with Severe Community-Acquired Pneumonia?: a Systemic Review and Meta-Analysis
por: Lee, Jong Hoo, et al.
Publicado: (2017) -
Trends of Cause of Death among Human Immunodeficiency Virus Patients and the Impact of Low CD4 Counts on Diagnosis to Death: a Retrospective Cohort Study
por: Kim, Yoonjung, et al.
Publicado: (2020) -
Significance and Associated Factors of Long-Term Sequelae in Patients after Acute COVID-19 Infection in Korea
por: Kim, Yoonjung, et al.
Publicado: (2021) -
New Scoring System for Predicting Mortality in Patients with COVID-19
por: Bae, Sohyun, et al.
Publicado: (2021) -
One Year Follow-Up of COVID-19 Related Symptoms and Patient Quality of Life: A Prospective Cohort Study
por: Kim, Yoonjung, et al.
Publicado: (2022)